Growing Awareness and Screening is Projected to The Urethritis Market Growth at a CAGR of 5.80% Over The Forecast Period 2023-2030

Pune, India, Nov, 2022 /MRFR Press Release/- Market Research Future has a half cooked research report on the global Urethritis market.

Market Highlights

The urethritis market is anticipated to grow at a CAGR of 5.80% from 2023 to 2030, reaching USD 1.25 billion.

Urethritis is inflammation of the urethra, or the tube that carries urine. The symptoms include burning sensation while urinating, presence of blood in the semen or urine, frequent urge and discomfort while urinating, abnormal discharge from the vagina or penis, etc. Untreated urethritis can lead to damage to the reproductive system, pelvic inflammatory disease (PID), and other serious conditions, which can lead to infertility. It is usually caused by infection by bacteria, or viral infection. According to the Centers for Disease Control and Prevention (CDC), Pathogen associated with urethritis include Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, human papillomavirus (HPV),  herpes simplex virus (HSV), and the Cytomegalovirus (CMV), and others. Urethritis is also caused by mechanical or chemical damage to the urethra during treatment or catheterization.

Females have a greater chance of developing urethritis than males because of the nearness of urethra to the anus and also men’s urethras is much longer than women’s. According to Antimicrobe, urethritis occured in approximately 4 million Americans in 2015 alone with Nongonococcal urethritis accounting for 80% of the cases. According to Department of Health, the U.K., urethritis accounts for 0.005% of hospital consulting with a high 97% of hospital consulting for urethritis requiring hospital admission. Almost 20% of hospital admissions for urethritis requires an emergency.

Rising demand due to growing population, increasing screening, rising number of geriatrics, rising safety and success of drug treatment, the extricating nature of the pain and others drive the growth of the market. The market restraints are the complications of treatment such as side effects, emergence of bacterial resistance to antibiotics, cost of treatment, and others

Product development represents the best strategy for the market growth. The market is expected to witness an exponential growth over the review period owing to technological advancement such as the development of broad spectrum antibiotics. Market development is another strategy for as there is a large unmet need in the developing regions such as India and China. Cost of the product may be a decisive factor in the developing regions such as Asia Pacific and Africa.

Key Market Players

Some of the key players profiled in the report are F. Hoffmann-La Roche AG, GlaxoSmithKline, AbbVie, Johnson & Johnson, and Merck & Co., Eli Lilly and Company, Bristol-Myers Squibb Company, Bayer AG, and AstraZeneca plc., and others.

Regional Analysis

The Americas accounts for a significant market share owing to high expenditure on the healthcare, especially, of the U.S. and Canada. Additionally, the greater number of hospitalization procedures due to greater healthcare penetration in the U.S. and Canada drives the market growth. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. The concentration of major healthcare players in the U.S. also add fuel to the growth of the market.

Europe is the second largest market in the world due to growing healthcare industry and healthcare penetration. The European market growth is led by countries such as Germany and France. Germany is expected to be the fastest growing market over the assessment period due to its large pharmaceutical industry.

Asia Pacific region is expected to grow rapidly; China and India are likely to lead this market due to fast growing healthcare sector and large unmet needs over the forecast period. South East Asian countries such as China, India, and Malaysia are projected to contribute highly to the market growth. The growing penetration of healthcare industry in the Asia Pacific region is expected to drive the future market in the region.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle East nations to watch out for are Kuwait, Jordan, Egypt and Iran. The African region is expected to witness a poor growth owing to poor economic and political conditions, and poor healthcare development. Other regions are expected to be laggards due to poor social development and tribal identities such as sub-Saharan Africa.

Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Urethritis Market” Research Report – Forecast till 2030.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Urethritis Market Research Report

Segmentation

The global urethritis market has been segmented on the basis of types, diagnosis, drug treatment and end user.

Based on the types, the market has been segmented as infective urethritis and nonspecific urethritis.

Based on the diagnosis, the market has been segmented as physical examination, microbial culture tests and others.

Based on the drug treatment, the market has been segmented as pain killer, anti-bacterial, antiviral, and others.

Based on the end user, the market has been segmented as hospitals and clinics, research and academics, and others.